CTOs on the Move

Velano Vascular

www.velanovascular.com

 
Velano Vascular aims to improve the hospital experience by reducing the pain, anxiety, and inefficiencies of blood draws.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Velano Vascular raised $17M on 03/07/2017
Velano Vascular raised $10M on 05/08/2019
Velano Vascular raised $25M on 12/17/2019

Similar Companies

Clarity Medical Systems

Clarity Medical Systems, Inc. is a medical device company that develops, manufactures and markets integrated optical systems and services to enhance the clinician`s ability to diagnose, manage, and treat eye disorders. These patented devices combine innovative 21st century optical, electronic and information technologies that change the very nature of eye healthcare. The Company`s initial product line has improved the standard of eye healthcare for pediatrics and is sold to leading Neonatal Intensive Care Units on a global basis. The Company`s first product line, the RetCam, is a major achievement in providing miniaturized, integrated, wide-field imaging for management of eye disorders in infants. The RetCam has revolutionized disease management for pediatric eye disorders and has been the enabling tool for several international clinical trials. Customers include: Stanford University, Bascom-Palmer Eye Institute, UCLA Jules Stein Eye Institute, Toronto Hospital for Sick Kids, Cleveland Clinic, USC Children`s Hospital, and Wills Eye Institute.

ACE Medical Equipment

ACE Medical Equipment is a Clearwater, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metamason

Metamason is dedicated to improving healthcare through technological innovation. Our health-focused software platform uses 3D scans of the body to create individually customized, 3D-printed products engineered for flawless fit.

Cordis

With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.

obius.jnj

obius.jnj is a Arcadia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.